Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, Ciuleanu T, Cucevic B, Gyurkovits K, Ulsperger E, Jassem J, Grgic M, Saip P, Szilasi M, Wiltschke C, Wagnerova M, Oskina N, Soldatenkova V, Zielinski C, Wenczl M; Central European Cooperative Oncology Group CECOG. Brodowicz T, et al. Among authors: grgic m. Lung Cancer. 2006 May;52(2):155-63. doi: 10.1016/j.lungcan.2006.01.006. Epub 2006 Mar 29. Lung Cancer. 2006. PMID: 16569462 Clinical Trial.
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.
Zielinski C, Beslija S, Mrsic-Krmpotic Z, Welnicka-Jaskiewicz M, Wiltschke C, Kahan Z, Grgic M, Tzekova V, Inbar M, Cervek J, Chernozemsky I, Szanto J, Spanik S, Wagnerova M, Ghilezan N, Pawlega J, Vrbanec D, Khamtsov D, Soldatenkova V, Brodowicz T. Zielinski C, et al. Among authors: grgic m. J Clin Oncol. 2005 Mar 1;23(7):1401-8. doi: 10.1200/JCO.2005.12.106. J Clin Oncol. 2005. PMID: 15735116 Clinical Trial.
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Effects of Interventions to Prevent Work-Related Asthma, Allergy, and Other Hypersensitivity Reactions in Norwegian Salmon Industry Workers (SHInE): Protocol for a Pragmatic Allocated Intervention Trial and Related Substudies.
Höper AC, Kirkeleit J, Thomassen MR, Irgens-Hansen K, Hollund BE, Fagernæs CF, Svedahl SR, Eriksen TE, Grgic M, Bang BE. Höper AC, et al. Among authors: grgic m. JMIR Res Protoc. 2023 Jul 19;12:e48790. doi: 10.2196/48790. JMIR Res Protoc. 2023. PMID: 37467018 Free PMC article.
UNILATERAL VS. DIFFUSE CHRONIC RHINOSINUSITIS.
Vrljičak A, Penezić A, Gregurić T, Grgić MV, Baudoin T, Kalogjera L. Vrljičak A, et al. Among authors: grgic mv. Acta Clin Croat. 2022 Oct;61(Suppl 4):63-69. doi: 10.20471/acc.2022.61.s4.8. Acta Clin Croat. 2022. PMID: 37250669 Free PMC article.
Toxicokinetics and bioaccumulation of silver sulfide nanoparticles in benthic invertebrates in an indoor stream mesocosm.
Silva PV, Silva ARR, Clark NJ, Vassallo J, Baccaro M, Medvešček N, Grgić M, Ferreira A, Busquets-Fité M, Jurkschat K, Papadiamantis AG, Puntes V, Lynch I, Svendsen C, van den Brink NW, Handy RD, van Gestel CAM, Loureiro S. Silva PV, et al. Among authors: grgic m. Sci Total Environ. 2023 May 15;873:162160. doi: 10.1016/j.scitotenv.2023.162160. Epub 2023 Feb 11. Sci Total Environ. 2023. PMID: 36775152
94 results